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The availability of monoclonal antibodies (mAb) 1 specific for human surface membrane antigens (1) has resulted in rapid progress toward elucidation of the nature of the molecules involved in cytolytic T lymphocyte (CTL)-target cell interactions. Since target cell lysis requires close contact between CTL and target cells, a general approach to this question has been the identification of mAb directed against CTL surface structures that inhibit cytolysis when added (in the absence of complement) to CTL-target cell mixtures (2) . For example, work from several groups showed that mAb against TS/Leu-2 and T3/Leu-4 surface molecules inhibit the cytolytic activity of T cell populations activated in allogeneic mixed lymphocyte culture (MLC) (3) (4) (5) (6) (7) (8) (9) . Recently, studies using CTL clones suggested that anti-T3 mAb inhibits the activity of all CTL irrespective of their T8/T4 phenotype, whereas anti-T8 and anti-T4 mAb selectively inhibit cytolysis mediated by T8 ÷ and T4 + CTL, respectively (10) . In the mouse, it has been well documented that mAb against Lyt-2/3, the murine homologue of T8 antigen, can inhibit CTL-mediated iysis (11) . However, the degree of inhibition obtained with anti-Lyt-2/3 mAb appears to be dependent on the source of CTL used. For example, the CTL activity of primary allogeneic MLC populations was found to be readily inhibited by anti-Lyt-2/3 mAb, whereas alloreactive CTL populations generated in vivo or in secondary (after priming in vitro) MLC were more difficult to inhibit under the same experimental conditions. The cellular basis for this difference has been clarified by the analysis of CTL clones derived from these populations. Thus, most (but not all) CTL clones derived from primary MLC were strongly inhibited by anti-Lyt-2/3 mAb, whereas, the activity of most (but not all) CTL clones derived from in vivo primed precursors was resistant to inhibition by these antibodies (12) . These studies strongly suggest that CTL are heterogeneous in their requirement for Lyt-2/3 molecules in cytolytic activity.
Recently, Malissen et al. (8) reported that B9.4 mAb (which appears to react with surface molecules bearing the Leu-2a/b and T8 antigenic determinants) (13) , inhibited only a minority of human CTL clones derived from an ailoimmune donor. Since this finding was reminiscent of the above-mentioned results in the mouse, we thought it of interest to determine whether there is heterogeneity in the involvement of molecules such as T8, T4, and T3 in the lytic activity of human CTE. Therefore, a large number of primary MLC-derived CTL clones were examined for their susceptibility to inhibition by mAb directed against T8, T4, and T3 molecules respectively. In agreement with the results obtained with murine Lyt-2 ÷ CTL, it will be shown that, although the majority of primary MLC-derived CTL clones expressing T8 antigen are inhibited by B9.4. mAb, ~15% are unaffected by this antibody. Moreover, a similar heterogeneity in the susceptibility to inhibition by the corresponding mAb has been documented for CTL clones expressing T4 molecules. Furthermore, evidence will be presented that the lytic activity of a significant proportion of CTL clones is unaffected by anti-T3 mAb. Finally, modulation experiments on CTL clones indicate that removal of surface T3 molecules is not always accompanied by the loss of specific cytolytic activity, thus suggesting that receptor structures on the CTL surface are not always functionally associated with T3 molecules.
Materials and Methods
Generation of Alloimmune CTL. Cytolytic T cells were generated in vitro in unidirectional mixed lymphocyte cultures (MLC) as previously described (14) . Briefly 106 peripheral blood T lymphocytes from normal donors were cultures with 106 irradiated (5,000 rads) allogeneic spleen cells for 7 d in macrowells (final volume 1 ml). The culture medium was RPMI 1640 containing 10% heat-inactivated fetal calf serum (FCS) (Gibco Laboratories, Grand Island, NY). Human spleens were removed for technical reasons during abdominal surgery. Mononuclear cell suspensions derived from spleens were frozen and subsequently thawed as needed (15) .
mAb. The B9.4 mAb (directed to T8 surface antigen) was kindly provided by Dr. C.
Mawas and B. Malissen (Centre d'Immunologie INSERM-CNRS, Marseille-Luminy, France), the 4F2 mAb was a gift of Dr. A. S. Fauci (National Institutes of Health, Bethesda, MD). OKT4 and OKT3 mAb were purchased from Ortho-Pharmaceuticais (Raritan, N J). Cytolytic Assay. The techniques used have been described in previous reports (16, 17) .
Briefly, various numbers of alloimmune primary MLC T cells or T cell clones were incubated for 4 h with ~Cr-labeled target cells (5 × 103/well) in a final volume of 200 #1 in "V'-bottomed microwells (Greiner Nurtinger, Federal Republic of Germany). Target cells were PHA-activated spleen-derived lymphoblasts bearing the sensitizing alloantigens or K 562 cells (in some control experiments). In the inhibition experiments, before the addition of target cells, MLC T cells or T cell clones were preincubated for 30 min at 20°C with various doses of B9.4, OKT4, or OKT3 mAb. B9.4 mAb was added at a final concentration of 1 ~g/microwell (5 ~g/ml) unless otherwise specified. OKT4 or OKT3 mAb were added in aliquots of 10 ~1 of the standard solution to each 200-ttl microweil, unless otherwise specified. When necessary, MLC ceils after preincubation with mAb were washed three times to remove the antibody. Microplates were centrifuged at 100 g for 5 rain and then incubated at 37°C. After 4 h, microplates were centrifuged again (200 g for 5 min) and 100 #1 supernatant was removed and counted for 1 min in a scintillation 51J counter. Percent specific Cr release was calculated as described previously (18) , whereas spontaneous release was determined in the absence of effector cells and maximal release was determined in the presence of 1 N hydrochloric acid.
Cloning of MLC Cells. This technique has been described in previous reports (19 Fig. 1 ), <5% of all cells had to be discarded because their fluorescence intensity coincided with the inflection point of the curve. Sorted cells were collected in sterile plastic tubes whose inside surfaces had been coated with sterile FCS. Once collected, cells were immediately diluted in culture medium.
Flow Cytofluorometric Analysis of TS, T4, and T3 Antigen Expression in Cloned CTL.
The techniques used have been described in detail elsewhere (17) . Briefly, aliquots of 10 s cells from a number of CTL clones were stained with monoclonal either B9.4, OKT4, or OKT3 antibodies followed by fiuorosceinated goat anti-mouse Ig. Control aliquots were stained with the fluorescent reagent alone. All samples were then analyzed on a flow cytometer (FACS II; Becton Dickinson, Mountain View, CA) gated to exclude nonviable cells. Further details of the FACS analysis are described elsewhere (21) . Results are expressed as arbitrarily normalized fluorescence histograms i.e., number of cells vs. fluorescence intensity.
Modulation of Surface T3 Antigen by OKT3 mAb.
Cells from clone A-11 or A-2, at 2 X 10n/ml, were incubated in the presence or absence of saturating amounts of OKT3 mAb. After 24 h the ceils were washed twice and analyzed for expression of T3 antigen (on a FACS II) and for specific CTL activity.
Results

Inhibitory Effect of B9.4 mAb on the Lytic Activity of Primary MLC-derived CTL Populations.
In a first series of experiments, primary MLC-derived CTL populations were tested for specific cytolytic activity in the presence or absence of graded amounts of anti-T8 B9.4 mAb. As shown in Fig. 1 , addition of B9.4 mAb resulted in a dose-dependent inhibition of cytolytic activity. It should be noted that the maximal level of inhibition never exceeded 85%, even in antibody excess. The inhibitory effect was found to be reversible since the lytic activity of MLC cells that had been pretreated with a saturating dose of antibody and washed before the cytolytic assay was similar to that of untreated MLC cells (data not shown). Under the same experimental conditions, 4F2 mAb, which reacts with a surface structure expressed by MLC-derived CTL and belongs to the same (3~ 2a) subclass as B9.4 mAb (22), was not inhibitory, even when added in large excess ( from MLC populations by limiting dilution or micromanipulation of single cells. As described previously (17) , the cloning efficiency in the microculture system we are using is 50-80%. After ] 4-18 d of culture, clones were tested for specific CTL activity in the presence or absence of 1 #g B9. be seen that CTL clones were heterogeneous in their susceptibility to inhibition of cytolysis by B9.4 mAb. While the majority of clones was either completely or strongly inhibited, seven clones were either unaffected or minimally inhibited. The lack of inhibition by B9.4 mAb could possibly be explained by the lack of corresponding antigen on the cell surface of these clones. In an attempt to clarify this point, we repeated this experiment using clones derived form MLC T8 ÷ populations that had been positively selected by FACS sorting of B9.4-stained cells. The CTL clones thus obtained were analyzed for susceptibility to inhibition by B9.4 mAb. The results of a representative experiment are shown in Fig. 3 . It can be seen that even within CTL clones selected on the basis of T8 antigen expression, a considerable degree of heterogeneity was observed. Of the 23 clones tested, 5 were unaffected in their activity by B9.4 mAb. In three different experiments, 13-22;% of T8 ÷ CTL clones belonged to the latter category. To further document this finding seven uninhibited clones were selected, expanded, and re-tested for lytic activity in the presence of increasing antibody concentrations. None of the seven clones showed any significant (>5%) inhibition even at doses of B9.4 as high as 5 #g. In a control experiment, 15 T8-CTL clones were selected and analyzed for their susceptibility to inhibition by B9.4 mAb. As expected, none of them was affected even in the presence of an excess (5 #g) of B9.4 mAb (data not shown).
Quantitative Analysis of T8 Antigen Expression on T8 + CTL Clones. The difference in susceptibility of T8 + CTL clones to inhibition by B9.4 mAb could be explained by a difference in the amount of T8 antigen expressed on the cell surface. This possibility was examined by assessing the level of T8 antigen on several inhibited and uninhibited clones. To this end, cell aliquots from each clone were incubated first with B9.4 mAb and then with a goat fluoresceinated antibody anti-mouse immunoglobulin, and then analyzed by flow microfluorometry. In parallel, the lytic activity of each clone was tested in the presence or absence of B0.4 mAb. In Fig. 4 are shown the fluorescence profiles of six representative CTL clones: the lytic activity of three of them (clones 4, 22, and 11) was completely blocked by B9.4 mAb, whereas the other three (clones 16, 39, and 17) were insensitive to the antibody. Although some quantitative variations in the expression of T8 antigen were observed among these clones, no correlation could be found between the amount of T8 antigen, the magnitude of cytolytic activity and the degree of inhibition of cytolysis by B9.4 mAb.
Clonal Analysis of CTL Inhibition by Anti-T4 mAb.
A similar approach was used to examine the inhibitory effect of anti-T4 mAb at the clonal level. T4 + cells were isolated from MLC populations by sorting using the FACS, and cloned by limiting dilution. Out of 212 clones obtained under these conditions, 14 were found to exhibit specific cytolytic activity against the stimulating allogeneic cells. These CTL clones were tested for expression of T4 antigen by indirect immunofluorescence on the FACS. As expected, all of them displayed the T4 + phenotype (data not shown). Analysis of the susceptibility of these T4 + clones to inhibition by anti-T4 mAb was performed as described above for T8 + CTL clones. As shown in Fig. 5 , there was a striking heterogeneity in the susceptibility of these T4 + CTL clones to inhibition of cytolysis by anti-T4 mAb. Indeed, only 6 of the 14 clones tested were affected by anti-T4 mAb. Further analysis indicated that seven of the eight uninhibited CTL clones were not affected even at a dose of anti-T4 mAb 10-fold higher than that sufficient for complete inhibition of susceptible clones. Moreover, no correlation was observed between the amount of T4 antigen expressed on the cell surface of a given clone and its susceptibility to inhibition by anti-T4 mAb (data not shown).
Clonal Analysis of CTL Inhibition by Anti-T3 mAb. It has been recently suggested
that the T3 surface molecule (which is expressed on CTL irrespective of their subset distribution) is closely linked to the T cell receptor structure (23, 24) . In view of the heterogeneity of inhibition observed with anti-T8 and anti-T4 mAb, it was of considerable interest to determine whether all CTL clones could be inhibited by anti-T3 mAb. To this end, the same sets of T8 + and T4 + CTL clones that had been tested above were analyzed for expression of T3 antigen as well as susceptibility to inhibition by anti-T3 mAb. In accordance with previous reports, all the clones analyzed expressed the T3 antigen as assessed by microfluorometry (data not shown). The inhibitory activity of anti-T3 mAb on T8 + CTL clones is shown in Fig. 6 . It can be seen that only 15 of the 23 CTL clones tested were clearly inhibited by anti-T3 mAb. Moreover, the number of clones that were not inhibited by anti-T3 mAb exceeded that of clones not inhibited by B9.4 mAb (eight vs. five). It is of interest that four of the five clones unaffected by B9.4 mAb were also resistant to anti-T3 mAb. Moreover, three clones were only inhibited by B9.4 mAb, whereas clones that were only inhibited by anti-T3 were relatively rare (1 out of 23 in the experiment reported in Fig. 6 ). Clones resistant to the standard amount of anti-T3 mAb were still unaffected by doses 10-fold higher of mAb (data not shown). The inhibitory effect of anti-T3 mAb on 14 T4 + CTL clones is shown in Fig. 7 . Again, both inhibited and not inhibited clones were clearly observed. While several clones were found to be resistant to both anti-T3 and anti-T4 mAbs, eight clones appeared to be sensitive only to anti-T3 mediated inhibition. It is noteworthy that the proportions of T4 + and T8 + CTL clones inhibited by anti-T3 mAb were comparable (72% and 65%, respectively).
Differential Effect ofT3 Modulation on the Lytic Activity of CTL Clones. It is well
documented that anti-T3 mAb can induce modulation of T3 molecules (10, 26) . Moreover, studies using CTL clones showed that modulation of T3 molecules was accompanied selectively by a loss of surface structures defined by anticlonotypic mAb, and resulted in a marked inhibition of cytolytic activity (24) . Given the fact that the clones used in these studies were susceptible to inhibition by anti-T3 mAb present during the cytolytic assay, we therefore investigated whether a similar effect could be observed with CTL clones that were resistant to inhibition by anti-T3 mAb. To this end, we selected two CTL clones, namely the clone A-11 which was resistant and the clone A-2 which, on the contrary, was highly susceptible to inhibition by anti-T3 mAb (Fig. 8) . Both clones expressed the T3 +, T8 ÷, T4-surface phenotype and were unable to lyse K 562 target cells. Incubation with anti-T3 mAb during 24 h at 37°C resulted in the loss of T3 molecules on the surface of both clones (Fig. 9) . However, when the modulated clones were tested in parallel for specific CTL activity, clone A-2 was found to exhibit little activity, whereas the lytic activity of clone A-11 was only minimally affected (<10% inhibition) by T3 modulation (Fig. 10) . (0) and A2 (A) before (--) and after (---) modulation of T3 surface antigne. The two clones were cultured in the presence or in the absence of saturating amounts ofOKT3 mAb for 24 h at 37°C. After extensive washing, graded numbers of cells were mixed with 5 x l0 s SlCr-labeled PHA-activated lymphoblasts bearing the sensitizing alloantigens, and cytolytic activity was determined after 4 h.
Discussion
that the lack of inhibitory activity of B9.4 or OKT4 mAb on some CTL clones could simply be explained by the lack of the corresponding structure on the effector cells. However, heterogeneity of inhibition was observed also among CTL clones bearing the corresponding molecules. Thus, although the majority of primary MLC-derived CTL clones expressing T8 molecules were either completely or strongly inhibited by B9.4 mAb, ~15% were inhibited minimally or unaffected. Interestingly, the susceptibility (or the lack thereof) of these clones to inhibition by B9.4 mAb did not correlate with the amount of T8 antigen expressed on the cell surface. Similarly, among T4 + CTL clones, some were completely inhibited by OKT4 mAb, whereas others were unaffected even by an excess of antibody.
In the clonal analysis performed by Meuer et al. (3) all the T8 + CTL clones examined were found to be susceptible to inhibition by anti-T8 mAb. In contrast, Malissen et al. (8) reported that only a minority of T8 + CTL clones were susceptible to inhibition by B9.4 mAb. These apparently conflicting findings can be reconciled on the basis of the data reported here, as well as the results obtained in the mouse concerning the role of the Lyt-2/3 antigen complex in CTL activity. As shown by MacDonald et al. (12) , there is considerable heterogeneity in the susceptibility of murine Lyt-2/3 + CTL to inhibition by mAb directed against Lyt-2 or Lyt-3 antigenic determinants. Moreover, the proportion of CTL clones that are unaffected by anti-Lyt-2/3 antibodies appears to be dependent on the source of CTL. In the study by MacDonald et al. (12) , <20% of CTL clones derived from MLC populations established with unprimed responder lymphocytes were not inhibited by anti-Lyt-2 mAb as compared to 60-75% of CTL clones obtained from in vivo immunized populations. In this context, it is noteworthy that the human CTL clones studied by Malissen et al. (8) , were derived from an allosensitized individual. As shown here, only a small fraction of human T8 ÷ CTL clones derived from primary MLC populations was unaffected by B9.4 mAb. It is therefore likely that the results of Meuer eta] . (3), who used T8 ÷ CTL clones derived from primary MLC populations, can be explained by the limited number of CTL clones examined. Taken together, all these results point to a striking functional similarity between the mouse Lyt-2/3 and the human T8 molecules, since in both instances, the resistance of CTL clones bearing these antigens to inhibition by the corresponding antibodies appears to correlate quantitatively (but not absolutely) with in vivo priming.
While Meuer et al. reported that T4 ÷ CTL clones were inhibited by anti-T4 mAb, opposite results were obtained by Spitz et al. (7) . From the work presented here, it is evident that, as in the case of T8 molecules, the requirement for T4 molecules in the cytolytic activity of T4 ÷ CTL exhibits clonal heterogeneity. It has been suggested that T8 and T4 molecules can act as associative recognition structures by virtue of their binding to the constant region of MHC class I or class II molecules, respectively (26) . Alternatively, as proposed by MacDonald et al. (27) to explain the clonal heterogeneity in the requirement for Lyt-2/3 molecules in the iytic activity of murine CTL, it can be speculated that the role of T8 and T4 molecules is to stabilize the binding of CTL receptors to the corresponding antigens. In either case, one would expect that CTL clones with high affinity receptors do not require additional surface molecules to mediate their function and therefore are not inhibited by anti-T8 or -T4 antibodies. Comparative studies using CTL clones derived from both unprimed and primed lymphoid cell populations might help to clarify this issue. Perhaps more importantly, the present study indicates that heterogeneity may also exist in the requirement of T3 molecules for CTL activity. Several lines of evidence suggest that T3 molecules are closely associated with T cell antigen receptors (24, 25, 28, 29) . Firstly, as already mentioned, the determinants recognized by mAb directed against clonotypic structures of CTL clones were found to be absent from the cell surface after modulation of T3 molecules by anti-T3 mAb. In addition, modulation of T3 molecules resulted in a marked reduction of the activity of such clones. Secondly, it has been shown that soluble anti-T3 mAb can inhibit the proliferative response of T cell clones to insolubilized anticlonotypic mAb. Finally, it appears that detectable amounts of molecules bearing clonotypic determinants can be co-precipitated by anti-T3 mAb. It should be emphasized, however, that the number of CTL clones used in all these studies has been very limited. Indeed, our work indicates that about two-thirds of the CTL clones derived from primary MLC populations required T3 molecules for target cell lysis. In contrast, the remaining clones, irrespective of their T4/T8 phenotype, did not appear to be dependent upon T3 molecules as indicated by the lack of inhibitory activity of anti-T3 mAb. In support of this contention is the demonstration that the cytolytic activity ofa CTL clone resistant to inhibition by anti-T3 mAb was unaffected by antibody-induced modulation of T3 molecules. This finding strongly suggest that T3 molecules and the clonotypic structures, which are thought to act as antigen receptors, are not always physically and functionally linked on the CTL surface. Further work using antibodies against clonotypic structures of CTL clones that are independent of T3 molecules is needed to ascertain directly this point. Moreover, it remains to be determined whether the proportion of T3-independent CTL is increased after in vivo priming.
Summary
In an attempt to define the requirement of T8, T4, and T3 surface molecules in functional interactions occurring between human cytolytic T lymphocytes (CTL) and specific target cells, we have analyzed a large number of CTL clones derived from primary mixed lymphocyte culture (MLC) T cell populations for their susceptibility to inhibition by monoclonai antibodies (mAb) directed against these surface antigens. In most experiments, MLC T cells were stained with B9.4 (anti-T8) or OKT4 (anti-T4) mAb, separated into positive and negative cells using a fluorescence-activated cell sorter (FACS) and cloned under limiting conditions. While the lytic activity of the majority of T8 + CTL clones was inhibited by B9.4 mAb, ~15% of these clones were unaffected even in the presence of excess antibody. Flow cytofluorometric analysis of T8 antigen in individual clones did not show any correlation between the amount of T8 antigen expressed, the magnitude of cytolytic activity and the susceptibility (or lack thereo{) to inhibition by B9.4 mAb. Of the 16 T4 + CTL clones analyzed, 7 were resistant to inhibition by OKT4 mAb even at doses 10-fold higher than that sufficient for complete inhibition of susceptible clones. Again, no correlation was found between the amount of T4 antigen expressed and the susceptibility to inhibition by the corresponding antibody.
The same sets of T8 + and T4 + CTL clones were also analyzed for their susceptibility to inhibition by OKT3 mAb. Although all of the clones expressed the T3 surface antigen, only 15/23 T8 + clones and 9/14 T4 + clones were inhibited by anti-T3 mAb. To further document this clonal heterogeneity, we selected two T3 + T4-T8 + CTL clones that had no concomitant NK-like activity. One clone was resistant to inhibition by OKT3 mAb, whereas the other was highly susceptible. Incubation with OKT3 mAb resulted in modulation of the T3 molecules in both clones. Following modulation, however, the cytolytic activity of the resistant $:lones was unaffected, whereas the lytic activity of the susceptible clone was abrogated. These results thus indicate extensive clonal heterogeneity in the requirement for T3, T4, and T8 molecules in CTL function. Moreover, it appears that T3 molecules are not always physically and functionally linked to CTL receptor structures.
